281 related articles for article (PubMed ID: 32824340)
1. NECTIN4 Expression in Extramammary Paget's Disease: Implication of a New Therapeutic Target.
Murata M; Ito T; Tanaka Y; Kaku-Ito Y; Furue M
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824340
[TBL] [Abstract][Full Text] [Related]
2. Trop2 Expression in Extramammary Paget's Disease and Normal Skin.
Ito T; Tanegashima K; Tanaka Y; Hashimoto H; Murata M; Oda Y; Kaku-Ito Y
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299325
[TBL] [Abstract][Full Text] [Related]
3. NECTIN4-targeted antibody-drug conjugate is a potential therapeutic option for extramammary Paget disease.
Tanaka Y; Ito T; Murata M; Tanegashima K; Kaku-Ito Y; Nakahara T
Exp Dermatol; 2024 Mar; 33(3):e15049. PubMed ID: 38509717
[TBL] [Abstract][Full Text] [Related]
4. KS-EMPD-1: a novel cell line of primary extramammary Paget's disease.
Ito T; Tanaka Y; Ichiki T; Kaku-Ito Y; Nakahara T
Hum Cell; 2023 Sep; 36(5):1813-1829. PubMed ID: 37432591
[TBL] [Abstract][Full Text] [Related]
5. NECTIN4 expression in sebaceous and sweat gland carcinoma.
Ito T; Hashimoto H; Tanaka Y; Tanegashima K; Murata M; Oda Y; Kaku-Ito Y
Eur J Dermatol; 2022 Apr; 32(2):181-186. PubMed ID: 35866909
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Janus kinase 2 protein in extramammary Paget's disease.
Otsuka-Maeda S; Mijiddorj MT; Kajihara I; Sakamoto R; Yamada-Kanazawa S; Kanemaru H; Nishimura Y; Sawamura S; Makino K; Aoi J; Makino T; Masuguchi S; Fukushima S; Ihn H
Jpn J Clin Oncol; 2021 Jul; 51(7):1176-1178. PubMed ID: 33912910
[TBL] [Abstract][Full Text] [Related]
7. Concordant overexpression of p-FAK and p-ERK1/2 in extramammary Paget's disease.
Chen SY; Moroi Y; Urabe K; Takeuchi S; Kido M; Hayashida S; Uchi H; Uenotsuchi T; Tu YT; Furue M
Arch Dermatol Res; 2008 Apr; 300(4):195-201. PubMed ID: 18210145
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of mucin genes in mammary and extramammary Paget's disease.
Kuan SF; Montag AG; Hart J; Krausz T; Recant W
Am J Surg Pathol; 2001 Dec; 25(12):1469-77. PubMed ID: 11717535
[TBL] [Abstract][Full Text] [Related]
9. Pagetoid variant of actinic keratosis with or without squamous cell carcinoma of sun-exposed skin: a lesion simulating extramammary Paget's disease.
Mai KT; Alhalouly T; Landry D; Stinson WA; Perkins DG; Yazdi HM
Histopathology; 2002 Oct; 41(4):331-6. PubMed ID: 12383215
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pathological characteristics of extramammary Paget's disease: report of 246 Chinese male patients.
Kang Z; Zhang Q; Zhang Q; Li X; Hu T; Xu X; Wu Z; Zhang X; Wang H; Xu J; Xu F; Guan M
Int J Clin Exp Pathol; 2015; 8(10):13233-40. PubMed ID: 26722523
[TBL] [Abstract][Full Text] [Related]
11. Podoplanin expression in peritumoral keratinocytes predicts aggressive behavior in extramammary Paget's disease.
Cho Z; Konishi E; Kanemaru M; Isohisa T; Arita T; Kawai M; Tsutsumi M; Mizutani H; Takenaka H; Ozawa T; Tsuruta D; Katoh N; Asai J
J Dermatol Sci; 2017 Jul; 87(1):29-35. PubMed ID: 28381343
[TBL] [Abstract][Full Text] [Related]
12. Novel ex vivo disease model for extramammary Paget's disease using the cancer tissue-originated spheroid method.
Arita T; Kondo J; Kaneko Y; Tsutsumi M; Kanemaru M; Matsui M; Arakawa Y; Katoh N; Inoue M; Asai J
J Dermatol Sci; 2020 Sep; 99(3):185-192. PubMed ID: 32800410
[TBL] [Abstract][Full Text] [Related]
13. The expression of HER-2 in extramammary Paget's disease.
Masuguchi S; Jinnin M; Fukushima S; Makino T; Sakai K; Inoue Y; Igata T; Ihn H
Biosci Trends; 2011 Aug; 5(4):151-5. PubMed ID: 21914949
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical and clinicopathological study regarding nardilysin on extramammary Paget's disease.
Yamaguchi A; Takahashi T; Kato T; Tanaka T; Nishi E; Fujimoto N
Arch Dermatol Res; 2023 Sep; 315(7):1979-1987. PubMed ID: 36867223
[TBL] [Abstract][Full Text] [Related]
15. Extramammary Paget's disease: a report of three cases and review of the literature.
Png JC; Tung KH; Wong YE; Mokal N; Rajagopalan R; Chong PY
Ann Acad Med Singap; 1995 Jul; 24(4):636-9. PubMed ID: 8849202
[TBL] [Abstract][Full Text] [Related]
16. Mammary and extramammary Paget's disease: expression of Ca 15-3, Ka-93, Ca 19-9 and CD44 in Paget cells and adjacent normal skin.
Tsuji T
Br J Dermatol; 1995 Jan; 132(1):7-13. PubMed ID: 7538778
[TBL] [Abstract][Full Text] [Related]
17. Cyclin-dependent kinase 4/6 inhibitors suppress tumor growth in extramammary Paget's disease.
Kitamura S; Yanagi T; Maeda T; Ujiie H
Cancer Sci; 2022 Feb; 113(2):802-807. PubMed ID: 34866279
[TBL] [Abstract][Full Text] [Related]
18. Cells of extramammary Paget's disease express cytokeratins different from those of epidermal cells.
Moll I; Moll R
J Invest Dermatol; 1985 Jan; 84(1):3-8. PubMed ID: 2578171
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor, androgen-producing enzymes and their transcription factors in extramammary Paget disease.
Azmahani A; Nakamura Y; Ozawa Y; McNamara KM; Fujimura T; Haga T; Hashimoto A; Aiba S; Sasano H
Hum Pathol; 2015 Nov; 46(11):1662-9. PubMed ID: 26359540
[TBL] [Abstract][Full Text] [Related]
20. miR-31 is distinctively overexpressed in primary male extramammary Paget's disease.
Guo H; Qi RQ; Lv YN; Wang HX; Hong YX; Zheng S; Li JH; Gao XH; Chen HD
Oncotarget; 2016 Apr; 7(17):24559-63. PubMed ID: 27016415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
